FOXA2 loss results in an increase of endometriosis development and LIF reveals a therapeutic effect for endometriosis
The FASEB Journal · 2025
DOI: 10.1096/fj.202403182r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Md Saidur Rahman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology and Women's Health, University of Missouri School of Medicine, Columbia, Missouri, USA. Hauptthemen laut MEDLINE: Endometriosis, Hepatocyte Nuclear Factor 3-beta, Leukemia Inhibitory Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Endometriosis, characterized by the growth of uterine‐like tissue outside the uterus, causes chronic pain and infertility. Current diagnostic and therapeutic strategies have notable limitations, including delayed diagnosis and adverse effects. The transcription factor forkhead box A2 (FOXA2), which is exclusively expressed in the uterine glandular epithelium, regulates key genes involved in endometrial proliferation, differentiation, fertility, and hormone response. While FOXA2 expression is reduced in the endometrial tissue of women with endometriosis, its pathophysiological role in the disease is not well understood. In this study, we report that endometriosis significantly reduced FOXA2 expression in the eutopic endometrium of mice with endometriosis compared to sham controls, accompanied by decreased expression of its downstream gene, CXCL15. To evaluate the effect of FOXA2 loss in endometriosis, we surgically induced endometriosis by transplanting control Rosa26 mTmG/+ or Pgr cre/+ Foxa2 f/f Rosa26 mTmG/+ ( Foxa2 d/d Rosa26 mTmG/+ ) endometrial tissue into the peritoneal cavity of mice. The number and weight of ectopic lesions were significantly increased in the mice with Foxa2 d/d Rosa26 mTmG/+ ectopic lesions compared to controls. Furthermore, progesterone receptor expression was significantly reduced in the endometrial epithelium from mice with Foxa2 d/d Rosa26 mTmG/+ ectopic lesions compared to mice with control ectopic lesions. Importantly, treatment with leukemia inhibitory factor (LIF), a cytokine regulated by FOXA2, significantly reduced ectopic lesion formation in Foxa2 d/d Rosa26 mTmG/+ endometriosis mice compared to vehicle‐treated mice. This study demonstrates that FOXA2 loss results in an increase in endometriosis incidence and that treatment with LIF offers a novel promising therapeutic approach for endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology and Women's Health, University of Missouri School of Medicine, Columbia, Missouri, USA.
ORCID-Profile: Md Saidur Rahman, Tae Hoon Kim, Breton F Barrier, Thomas E Spencer, Andrew M Kelleher, Jae-Wook Jeong
Förderung
- NICHD NIH HHS
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Rahman, M. S., Kim, T. H., Barrier, B. F., Spencer, T. E., Kelleher, A. M., & Jeong, J. W. (2025). FOXA2 loss results in an increase of endometriosis development and LIF reveals a therapeutic effect for endometriosis. The FASEB Journal. https://doi.org/10.1096/fj.202403182r
Vancouver
Rahman MS, Kim TH, Barrier BF, Spencer TE, Kelleher AM, Jeong JW. FOXA2 loss results in an increase of endometriosis development and LIF reveals a therapeutic effect for endometriosis. The FASEB Journal. 2025. doi:10.1096/fj.202403182r
BibTeX
@article{Rahman2025,
author = {Rahman, Md Saidur and Kim, Tae Hoon and Barrier, Breton F and Spencer, Thomas E and Kelleher, Andrew M and Jeong, Jae-Wook},
title = {FOXA2 loss results in an increase of endometriosis development and LIF reveals a therapeutic effect for endometriosis},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403182r}
}
EUVIMED